Jenburkt Pharmaceuticals
₹1,162.35
+33.25 (2.94%)
23 November, 2024 15:31 BSE: 524731
NSE: JENBURPHISIN: INE354A01013
Start SIP in Jenburkt Pharmaceuticals
Start SIPJenburkt Pharmaceuticals Performance
Day Range
52 Week Range
Jenburkt Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,162.35
+33.25 (2.94%)
- Bullish Moving Average
- ___
- 13
- Bearish Moving Average
- ___
- 3
- 20 Day
- ₹1,132.23
- 50 Day
- ₹1,084.80
- 100 Day
- ₹1,026.21
- 200 Day
- ₹939.70
- 20 Day
- ₹1,107.07
- 50 Day
- ₹1,081.62
- 100 Day
- ₹1,023.13
- 200 Day
- ₹903.08
Jenburkt Pharmaceuticals Resistance and Support
PIVOT
₹1,150.79
Resistance | |
---|---|
First Resistance | 1,186.57 |
Second Resistance | 1,210.78 |
Third Resistance | 1,246.57 |
RSI | 54.38 |
MFI | 75.28 |
MACD Single Line | 34.90 |
MACD | 36.68 |
Support | |
---|---|
First Support | 1,126.57 |
Second Support | 1,090.78 |
Third Supoort | 1,066.57 |
Jenburkt Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 2,660 | 213,492 | 80.26 |
Week | 3,120 | 211,006 | 67.63 |
1 Month | 4,379 | 320,568 | 73.2 |
6 Month | 3,577 | 275,859 | 77.13 |
Jenburkt Pharmaceuticals Result Highlights
Jenburkt Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Jenburkt Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-11-05 | Quarterly Results | |
2024-07-26 | Quarterly Results | |
2024-05-28 | Audited Results & Dividend | |
2024-02-06 | Quarterly Results | |
2023-11-07 | Quarterly Results |